In yet another damning indictment of the dangers and ineffectiveness of cancer drugs, new research carried out in the UK has found that, in some hospitals, within 30 days of starting treatment, chemotherapy is killing up to 50 per cent of patients who receive it. With even the normally pro-pharma British media expressing shock and saying patients should be warned about the dangers of these toxic chemical treatments, the study provides further evidence that the credibility of chemotherapy as a cure for cancer is collapsing.
Using data from a full 12-month period in 2014, the study included 23,228 patients with breast cancer and 9,634 patients with non-small cell lung cancer, all of whom were 24 years of age or older. While death rates varied across different regions of the UK, the study clearly showed that chemotherapy, as opposed to the cancer itself, was killing hundreds of patients within 30 days of treatment commencing.
In further bad news for the Pharma Cartel, another new study has shown that adding additional chemotherapy drugs doesn’t improve the treatment of osteosarcoma, a type of bone cancer.
Published in The Lancet Oncology journal, the trial examined more than 600 osteosarcoma patients in 17 countries for whom chemotherapy treatment had already failed. The results proved that adding two further chemotherapy drugs to the standard protocol for this bone cancer did not improve patient survival. Moreover, the increased toxic load that the drugs imposed upon patients predictably led to more side effects.
In a press release published on the Stanford University Medical Center website, the study’s lead author, Neyssa Marina, MD, a professor of pediatrics, stressed the significance of the finding by admitting that in the past she had been “treating a lot of patients with these drugs without realizing that they weren’t helping.”
With a chronic deficiency of vitamins, amino acids, and other specific micronutrients now known to be the primary cause of today’s most common chronic diseases, chemotherapy is not – and will never be – a cure for cancer. Instead, and as growing numbers of patients are testifying, victory over cancer is possible using safe, effective, natural approaches.
Cellular Medicine research conducted at the Dr. Rath Research Institute has clearly shown that cancers of the cervix, bladder, kidney, skin, ovary, pancreas, breast, bone, prostate, colon and lung – as well as lymphomas, leukemia, and sarcomas in both adults and children – can be controlled using the micronutrient synergy approach. Through the proper selection and correct combining of micronutrients, these studies are paving the way towards cancer becoming a manageable disease.
Unlike the “shotgun” approach of chemotherapy, which cannot distinguish between cancer cells and normal cells, Cellular Medicine therapies are scientifically proven to safely and effectively block all key mechanisms that make cancer a deadly disease. Such mechanisms include inhibiting the invasion and metastasis of cancer cells, curbing blood supply (angiogenesis) in tumors, and inducing cancer cell death (apoptosis).
With each passing day, more and more cancer patients are learning about the Cellular Medicine approach to cancer. Empowered through realizing that a cancer-free world is possible, they are turning their backs on toxic chemotherapy and taking their own decisions about what is best for their health. If enough of us become active in sharing the facts about natural cancer treatment as widely as possible, needless suffering and deaths from chemotherapy can be avoided and, as a result, millions of lives saved.